| |
Total (n = 50)
|
|---|
|
Age, (years)
|
51 ± 21
|
|
Range
|
10–83
|
|
Male, n (%)
|
33 (66)
|
|
Witnessed, n (%)
|
36 (72)
|
|
Bystander CPR, n (%)
|
32 (64)
|
|
Initial rhythms at the scene
| |
|
VF/pulseless VT, n (%)
|
37 (74)
|
|
Asystole/PEA, n (%)
|
13 (26)
|
|
Initial rhythms on arrival
| |
|
VF/pulseless VT, n (%)
|
27 (54)
|
|
Asystole/PEA, n (%)
|
23 (46)
|
|
BLS-TOR rule
| |
|
Satisfied, n (%)
|
7 (14)
|
|
Unsatisfied, n (%)
|
43 (86)
|
|
ALS-TOR rule
| |
|
Satisfied, n (%)
|
1 (2)
|
|
Unsatisfied, n (%)
|
49 (96)
|
|
Comorbid diseases
| |
|
Cardiac diseases, n (%)
|
13 (26)
|
|
Other, n (%)
|
3 (6)
|
|
Circulatory arrest time, min
|
7.4 ± 10.4
|
|
CPR duration, min
|
84 ± 48
|
|
Door to ECPR initiation, min
|
37 ± 22
|
|
ECMO duration, h
|
38 ± 49
|
- Data are presented as n (%) or mean ± standard deviation. CPR cardiopulmonary resuscitation, VF ventricular fibrillation, VT ventricular tachycardia PEA pulseless electrical activity, BLS basic life support, ALS advanced life support, TOR termination of resuscitation, ECPR extracorporeal cardiopulmonary resuscitation, ECMO extracorporeal membrane oxygenation.
